. 2012 Sep 12;7(9):e44775. doi: 10.1371/journal.pone.0044775

Table 4. Available ACT brands observed on the survey day in PMV stores in Jigawa, Nigeria^*.

Policy	Brand (generic)	No. of PMV in SD^†			Weighted State Aggregate	CI^‡
		C	NE	NW
MOH approved	Coartem (AL)	0	3	2	22.96%	±8.12
	Arsuamoon (AA)	1	1	1	14.29%	±7.63
	Malact (AA)	0	2	0	9.18%	±5.48
	Nexanate (AA)	0	0	0	0%	±0
Not MOH approved	Others	2	4	3	42.35%	±10.44

Multiple responses were allowed; no LQAS judgments made, because list includes adequate and inadequate behavior, i.e. stocking and selling of brands that are MOH approved and non-approved for treatment of uncomplicated malaria in Nigeria.

^†

Number of PMVs in the sample of 7 PMVs per Sub-District (SD) who had brands in stock as observed on survey day.

^‡

95% confidence intervals for state estimates of coverage with finite population correction.

MOH = Ministry of Health, AL = Arthemether-lumefantrine, AA = Artesunate-amodiaquine.

Table 4. Available ACT brands observed on the survey day in PMV stores in Jigawa, Nigeria*.

Table 4. Available ACT brands observed on the survey day in PMV stores in Jigawa, Nigeria^*.